DAZIVIB M DESLORATADINE 5mg. IP + MONTELUKAST 10mg. IP

Dazivib M tablets combine Desloratadine 5 mg and Montelukast 10 mg for allergic rhinitis symptoms and hives when alternatives do not suit. Main uses: relief of nasal and non-nasal symptoms of seasonal allergic rhinitis, reserved for patients who do not respond to or cannot take other therapies; relief of nasal and non-nasal symptoms of perennial allergic rhinitis, reserved for patients who do not respond to or cannot take other therapies; symptomatic relief of itching in chronic idiopathic urticaria; reduction in the number and size of hives in chronic idiopathic urticaria.

Common side effects of Dazivib M Tablet include headache; dry mouth; drowsiness or somnolence; tiredness or fatigue; sore throat (pharyngitis); muscle pain (myalgia). Get medical help at once if you notice hypersensitivity reactions including rash, swelling, difficulty breathing and anaphylaxis; stop the medicine and seek care at once; serious neuropsychiatric events such as agitation, aggression, depression, sleep disturbances and suicidal thoughts or behaviour; systemic eosinophilia, sometimes with features of a vasculitis (Churg-Strauss syndrome), reported mainly when steroid doses were reduced.

Each Dazivib M tablet contains Desloratadine 5 mg + Montelukast 10 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Dazivib M Tablet only as your doctor advises.

The MRP of Dazivib M Tablet is ₹179 for a pack of 10x10 (Alu Alu). For chemists and distributors, the PTR is ₹136.38 and the PTS is ₹122.74.

Each Dazivib M tablet contains Desloratadine 5 mg + Montelukast 10 mg. It comes in a pack of 10x10 (Alu Alu).

In this combination, Desloratadine acts as an H1 antihistamine. It blocks the histamine receptors that drive sneezing, itching, a runny nose and hives during an allergic reaction. Montelukast works on a different pathway as a leukotriene receptor antagonist. It blocks cysteinyl leukotrienes released in the nasal lining and airways after allergen exposure, easing swelling, congestion and nasal symptoms during both early and late allergic reactions.

Must not be used by patients who are allergic to desloratadine, loratadine, montelukast or any ingredient of the tablet. Must not be used to treat an acute asthma attack; keep an appropriate rescue medicine available. Check with a doctor first if you are pregnant or breastfeeding. Check with a doctor first if you are sensitive to aspirin or other painkillers; continue to avoid aspirin and NSAIDs. Check with a doctor first if you have a history of mental health problems, and do not suddenly replace inhaled or oral steroids with this tablet.

Dazivib M Tablet is a brand of Vibcare Pharma, sold through its Prima division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.